{
  "symbol": "AARTIPHARM.NS",
  "period": "quarterly",
  "data": [
    {
      "ticker": "AARTIPHARM.NS",
      "date": "2024-06-30",
      "quarter": "Q2 2024",
      "fiscal_year": 2024,
      "revenue": null,
      "gross_profit": null,
      "operating_income": null,
      "ebitda": null,
      "net_income": null,
      "diluted_eps": null,
      "total_assets": null,
      "total_liabilities": null,
      "total_equity": null,
      "total_debt": null,
      "cash_and_equivalents": null,
      "current_assets": null,
      "current_liabilities": null,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 28.277168,
      "peg_ratio": null,
      "pb_ratio": 3.3087876,
      "ps_ratio": 3.551549,
      "price_target_high": null,
      "price_target_low": null,
      "price_target_avg": null,
      "promoter_holding": 0.44566002,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": 2.5,
      "splits": null,
      "buybacks": 90647294,
      "debt_to_equity": null,
      "current_ratio": null,
      "operating_margin": null,
      "net_profit_margin": null,
      "roe": null,
      "roa": null,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": null,
      "revenue_growth_yoy": null,
      "ebitda_growth_yoy": null
    },
    {
      "ticker": "AARTIPHARM.NS",
      "date": "2024-09-30",
      "quarter": "Q3 2024",
      "fiscal_year": 2024,
      "revenue": 4580258000.0,
      "gross_profit": 2290525000.0,
      "operating_income": 727904000.0,
      "ebitda": 981564000.0,
      "net_income": 546225000.0,
      "diluted_eps": null,
      "total_assets": 27765119000.0,
      "total_liabilities": 9197852000.0,
      "total_equity": 18567267000.0,
      "total_debt": 3864698000.0,
      "cash_and_equivalents": 408079000.0,
      "current_assets": 13766735000.0,
      "current_liabilities": 6834873000.0,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 28.277168,
      "peg_ratio": null,
      "pb_ratio": 3.3087876,
      "ps_ratio": 3.551549,
      "price_target_high": null,
      "price_target_low": null,
      "price_target_avg": null,
      "promoter_holding": 0.44566002,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": 2.5,
      "splits": null,
      "buybacks": 90647294,
      "debt_to_equity": 0.20814576534069337,
      "current_ratio": 2.014190314874907,
      "operating_margin": 15.892205198921108,
      "net_profit_margin": 11.925638250072376,
      "roe": 2.9418707664407475,
      "roa": 1.9673065330640216,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 21.4303211740474,
      "revenue_growth_yoy": null,
      "ebitda_growth_yoy": null
    },
    {
      "ticker": "AARTIPHARM.NS",
      "date": "2024-12-31",
      "quarter": "Q4 2024",
      "fiscal_year": 2024,
      "revenue": 5377782000.0,
      "gross_profit": 2624704000.0,
      "operating_income": 1055722000.0,
      "ebitda": 1336375000.0,
      "net_income": 739879000.0,
      "diluted_eps": null,
      "total_assets": null,
      "total_liabilities": null,
      "total_equity": null,
      "total_debt": null,
      "cash_and_equivalents": null,
      "current_assets": null,
      "current_liabilities": null,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 28.277168,
      "peg_ratio": null,
      "pb_ratio": 3.3087876,
      "ps_ratio": 3.551549,
      "price_target_high": null,
      "price_target_low": null,
      "price_target_avg": null,
      "promoter_holding": 0.44566002,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": 2.5,
      "splits": null,
      "buybacks": 90647294,
      "debt_to_equity": null,
      "current_ratio": null,
      "operating_margin": 19.631178801967057,
      "net_profit_margin": 13.758069776722076,
      "roe": null,
      "roa": null,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 24.84992883683273,
      "revenue_growth_yoy": null,
      "ebitda_growth_yoy": null
    },
    {
      "ticker": "AARTIPHARM.NS",
      "date": "2025-03-31",
      "quarter": "Q1 2025",
      "fiscal_year": 2025,
      "revenue": 5347046000.0,
      "gross_profit": 1653709000.0,
      "operating_income": 1228106000.0,
      "ebitda": 1440188000.0,
      "net_income": 883409000.0,
      "diluted_eps": null,
      "total_assets": 29064051000.0,
      "total_liabilities": 9164987000.0,
      "total_equity": 19899064000.0,
      "total_debt": 4208179000.0,
      "cash_and_equivalents": 67337000.0,
      "current_assets": 13221672000.0,
      "current_liabilities": 6570495000.0,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 28.277168,
      "peg_ratio": null,
      "pb_ratio": 3.3087876,
      "ps_ratio": 3.551549,
      "price_target_high": null,
      "price_target_low": null,
      "price_target_avg": null,
      "promoter_holding": 0.44566002,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": 2.5,
      "splits": null,
      "buybacks": 90647294,
      "debt_to_equity": 0.21147622822862422,
      "current_ratio": 2.012279440133506,
      "operating_margin": 22.967934070512953,
      "net_profit_margin": 16.52144006241951,
      "roe": 4.439450016342477,
      "roa": 3.0395246691522804,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 26.934273615749703,
      "revenue_growth_yoy": null,
      "ebitda_growth_yoy": null
    },
    {
      "ticker": "AARTIPHARM.NS",
      "date": "2025-06-30",
      "quarter": "Q2 2025",
      "fiscal_year": 2025,
      "revenue": 3861909000.0,
      "gross_profit": 2167855000.0,
      "operating_income": 724501000.0,
      "ebitda": 950418000.0,
      "net_income": 495012000.0,
      "diluted_eps": null,
      "total_assets": null,
      "total_liabilities": null,
      "total_equity": null,
      "total_debt": null,
      "cash_and_equivalents": null,
      "current_assets": null,
      "current_liabilities": null,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 28.277168,
      "peg_ratio": null,
      "pb_ratio": 3.3087876,
      "ps_ratio": 3.551549,
      "price_target_high": null,
      "price_target_low": null,
      "price_target_avg": null,
      "promoter_holding": 0.44566002,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": 2.5,
      "splits": null,
      "buybacks": 90647294,
      "debt_to_equity": null,
      "current_ratio": null,
      "operating_margin": 18.760177932727053,
      "net_profit_margin": 12.817805908942962,
      "roe": null,
      "roa": null,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 24.610056839764997,
      "revenue_growth_yoy": null,
      "ebitda_growth_yoy": null
    },
    {
      "ticker": "AARTIPHARM.NS",
      "date": "2025-09-30",
      "quarter": "Q3 2025",
      "fiscal_year": 2025,
      "revenue": 4183348000.0,
      "gross_profit": 2085586000.0,
      "operating_income": 499495000.0,
      "ebitda": 741266000.0,
      "net_income": 279231000.0,
      "diluted_eps": null,
      "total_assets": 32659045000.0,
      "total_liabilities": 12196989000.0,
      "total_equity": 20462056000.0,
      "total_debt": 6587778000.0,
      "cash_and_equivalents": 321936000.0,
      "current_assets": 13262980000.0,
      "current_liabilities": 8106226000.0,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 28.277168,
      "peg_ratio": null,
      "pb_ratio": 3.3087876,
      "ps_ratio": 3.551549,
      "price_target_high": null,
      "price_target_low": null,
      "price_target_avg": null,
      "promoter_holding": 0.44566002,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": 2.5,
      "splits": null,
      "buybacks": 90647294,
      "debt_to_equity": 0.32195093200800545,
      "current_ratio": 1.6361473267584694,
      "operating_margin": 11.940077660285493,
      "net_profit_margin": 6.674821219750306,
      "roe": 1.3646282660940816,
      "roa": 0.854988258229841,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 17.719443852149045,
      "revenue_growth_yoy": -8.665669051830704,
      "ebitda_growth_yoy": -24.481134189925466
    }
  ]
}